Donna Milne Selected Research

Immunotherapy

1/2023	Feasibility and preliminary effectiveness of virtual reality as a patient education tool for people with cancer undergoing immunotherapy: a protocol for a randomised controlled pilot study in a regional setting.
1/2021	Co-design and development of online video resources about immunotherapy with patients and their family.
1/2021	Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners.
9/2020	Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma.
3/2020	Exploring the Experiences of People Treated With Immunotherapies for Advanced Melanoma and Those Caring for Them: "Real-World" Data.
1/2020	i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol.
11/2019	Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?
1/2019	Exercise Behaviors and Fatigue in Patients Receiving Immunotherapy for Advanced Melanoma: A Cross-Sectional Survey via Social Media.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donna Milne Research Topics

Disease

10	Melanoma (Melanoma, Malignant) 01/2021 - 12/2017
5	Neoplasms (Cancer) 01/2023 - 05/2012
3	Fatigue 03/2020 - 01/2019
1	Disease Progression 05/2020

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 01/2021 - 08/2019
2	IpilimumabIBA 05/2020 - 01/2020
2	Monoclonal AntibodiesIBA 05/2020 - 12/2017
2	pembrolizumabIBA 01/2020 - 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2020
1	NivolumabIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2019
1	dimyristoylphosphatidylinositolIBA 01/2018
1	AntibodiesIBA 12/2017

Therapy/Procedure

8	Immunotherapy 01/2023 - 01/2019
2	Therapeutics 01/2021 - 09/2020
2	Radiotherapy 01/2019 - 05/2012
2	Palliative Care (Palliative Therapy) 12/2017 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2019
1	Meditation 01/2018